
CGRP antagonists and dietary changes show promise for migraine treatment
Researchers reviewed recent advancements in migraine therapy, specifically the classification of the disease and clinical and diet intervention advancements aimed at significantly reducing the frequency, pain, and severity of attacks. They found that CGRP receptor antagonists and monoclonal antibodies, along with dietary and physical activity modifications, can substantially increase the number of migraine-free monthly days…